Who makes Médialipides?

Médialipides is developed by Centre Hospitalier Universitaire de Nice.

What development phase is Médialipides in?

Médialipides is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Médialipides

Centre Hospitalier Universitaire de Nice · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Médialipides
Sponsor	Centre Hospitalier Universitaire de Nice
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Médialipides CI brief — competitive landscape report
Médialipides updates RSS · CI watch RSS
Centre Hospitalier Universitaire de Nice portfolio CI